Dabigatran impurity standards
For Dabigatran, the Zemixal catalogue holds 77 impurity and reference standards that support release testing, stability programmes and regulatory dossiers. Counted by type, there are 1 pharmacopoeial impurity, 4 nitrosamines, 2 isotope-labelled standards, 1 metabolite or hydroxylated analogue and 2 degradation products.
Each lot ships with a certificate of analysis, and characterisation data such as 1H-NMR, mass spectrum and HPLC purity can be shared before you order. Laboratories use them to validate related-substance methods, set specification limits under ICH Q3A and Q3B, and identify unknown peaks in stability samples. For nitrosamine risk evaluation, the N-nitroso standards allow confirmatory LC-MS testing against the acceptable intake limits.
By impurity type
Counts are based on product names. One compound can fall into more than one type.
All Dabigatran reference materials
- CAS
- 1848337-06-3
- Formula
- C24H29N5O4
- MW
- 451.5 g/mol
- CAS
- 211914-50-0
- Formula
- C27H30ClN7O3
- MW
- 536 g/mol
- CAS
- 847785-94-8
- Formula
- C23H26N2O2
- MW
- 362.5 g/mol
- CAS
- 1354727-65-3
- Formula
- C29H33ClN6O4
- MW
- 565.1 g/mol
- CAS
- 1422435-40-2
- Formula
- C19H20N4O3
- MW
- 352.4 g/mol
- CAS
- 1642853-67-5
- Formula
- C19H20N4O4
- MW
- 368.4 g/mol